Wolf Haldenstein Announces Investigation of Unilife Corp. Business Wire NEW YORK -- November 11, 2013 Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a leading securities law firm, announces that it is investigating claims of misconduct by the senior management and Board of Directors of Unilife Corp. (NASDAQ:UNIS). Wolf Haldenstein believes that possible malfeasance by the senior management and Board of Directors has caused and will continue to cause Unilife Corp. and its shareholders significant harm. The investigation concerns whether members of senior management and the Board of Directors breached their fiduciary duties to the Company and to shareholders by disseminating false information and attempting to mislead investors and the market in contravention of federal securities laws. Wolf Haldenstein is also investigating potential violations of Food and Drug Administration regulations and claims of corporate waste and mismanagement by Unilife Corp.’s senior management and Board of Directors. A complaint has been filed in the United States District Court for the Middle District of Pennsylvania on behalf of all persons or entities that purchased the common stock of Unilife Corporation (“between July 13, 2011 and September 9, 2013, inclusive alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”). If you wish to serve as lead plaintiff, you must move the Court no later than December 31, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. While Wolf Haldenstein did not file the Complaint in this matter, the firm, with offices in New York, Chicago and San Diego and currently celebrating its 125^th year of providing exemplary legal services to its clients, has represented individual and institutional investors for many years, serving as lead counsel in numerous cases in United States federal and state courts. Please visit the Wolf Haldenstein website (http://www.whafh.com) for more information about the firm and its attorneys. If you are a shareholder of Unilife Corp. (NASDAQ: UNIS) who purchased shares between July 13, 2011 and September 9, 2013 and have suffered a loss, and wish to discuss this action or have any questions concerning this notice or your rights or interests please contact us at: Gregory M. Nespole, Esq. Wolf Haldenstein Adler Freeman & Herz LLP 270 Madison Avenue New York, New York 10016 Phone Numbers: (800) 575-0735 (212) 545-4657 (917) 515-6161 Email: Classmember@whafh.com or firstname.lastname@example.org and please reference “Unilife Corp.” Attorney Advertising. Prior results do not guarantee a similar outcome Contact: Wolf Haldenstein Adler Freeman & Herz LLP Gregory M. Nespole, Esq. 800-575-0735 212-545-4657 917-515-6161 Classmember@whafh.com or email@example.com
Wolf Haldenstein Announces Investigation of Unilife Corp.
Press spacebar to pause and continue. Press esc to stop.